Literature DB >> 25451922

BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.

Yuki Okino1, Yuka Machida1, Sarah Frankland-Searby2, Yuichi J Machida3.   

Abstract

BRCA1-associated protein 1 (BAP1), which is frequently mutated in cancer, functions as a deubiquitinase (DUB) for histone H2A. Although BAP1 interacts with a transcriptional regulator, HCF-1, and transcription factors FoxK1 and FoxK2, how BAP1 controls gene expression remains unclear. This study investigates the importance of BAP1 DUB activity and the interactions with FoxK2 and HCF-1 in the regulation of FoxK2 target genes. We show that FoxK2 recruits BAP1 to the target genes through the forkhead-associated domain, which interacts with Thr(P)-493 on BAP1. BAP1, in turn, recruits HCF-1, thereby forming a ternary complex in which BAP1 bridges FoxK2 and HCF-1. BAP1 represses FoxK2 target genes, and this effect requires BAP1 DUB activity but not interaction with HCF-1. Importantly, BAP1 depletion causes up-regulation of FoxK2 target genes only in the presence of the Ring1B-Bmi1 complex, an E3 ubiquitin ligase for histone H2A, indicating an antagonizing role of BAP1 against Ring1B-Bmi1. Our findings suggest that BAP1 deficiency causes increased expression of target genes in a Ring1B-Bmi1-dependent manner.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Deubiquitylation (Deubiquitination); Gene Expression; Phosphorylation; Tumor Suppressor Gene; Ubiquitin

Mesh:

Substances:

Year:  2014        PMID: 25451922      PMCID: PMC4340404          DOI: 10.1074/jbc.M114.609834

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Authors:  Matthew Bott; Marie Brevet; Barry S Taylor; Shigeki Shimizu; Tatsuo Ito; Lu Wang; Jenette Creaney; Richard A Lake; Maureen F Zakowski; Boris Reva; Chris Sander; Robert Delsite; Simon Powell; Qin Zhou; Ronglai Shen; Adam Olshen; Valerie Rusch; Marc Ladanyi
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

2.  Loss of the tumor suppressor BAP1 causes myeloid transformation.

Authors:  Anwesha Dey; Dhaya Seshasayee; Rajkumar Noubade; Dorothy M French; Jinfeng Liu; Mira S Chaurushiya; Donald S Kirkpatrick; Victoria C Pham; Jennie R Lill; Corey E Bakalarski; Jiansheng Wu; Lilian Phu; Paula Katavolos; Lindsay M LaFave; Omar Abdel-Wahab; Zora Modrusan; Somasekar Seshagiri; Ken Dong; Zhonghua Lin; Mercedesz Balazs; Rowena Suriben; Kim Newton; Sarah Hymowitz; Guillermo Garcia-Manero; Flavius Martin; Ross L Levine; Vishva M Dixit
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

Review 3.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

4.  Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors.

Authors:  Xiaozhong Shi; David C Seldin; Daniel J Garry
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

5.  A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

Authors:  Megan N Farley; Laura S Schmidt; W Marston Linehan; James Brugarolas; Jessica L Mester; Samuel Pena-Llopis; Andrea Pavia-Jimenez; Alana Christie; Cathy D Vocke; Christopher J Ricketts; James Peterson; Lindsay Middelton; Lisa Kinch; Nick Grishin; Maria J Merino; Adam R Metwalli; Chao Xing; Xian-Jin Xie; Patricia L M Dahia; Charis Eng
Journal:  Mol Cancer Res       Date:  2013-05-24       Impact factor: 5.852

6.  Germline BAP1 mutations predispose to renal cell carcinomas.

Authors:  Tatiana Popova; Lucie Hebert; Virginie Jacquemin; Sophie Gad; Virginie Caux-Moncoutier; Catherine Dubois-d'Enghien; Bénédicte Richaudeau; Xavier Renaudin; Jason Sellers; André Nicolas; Xavier Sastre-Garau; Laurence Desjardins; Gabor Gyapay; Virginie Raynal; Olga M Sinilnikova; Nadine Andrieu; Elodie Manié; Antoine de Pauw; Paul Gesta; Valérie Bonadona; Christine M Maugard; Clotilde Penet; Marie-Françoise Avril; Emmanuel Barillot; Odile Cabaret; Olivier Delattre; Stéphane Richard; Olivier Caron; Meriem Benfodda; Hui-Han Hu; Nadem Soufir; Brigitte Bressac-de Paillerets; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Am J Hum Genet       Date:  2013-05-16       Impact factor: 11.025

7.  Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.

Authors:  Yuchen Jiao; Timothy M Pawlik; Robert A Anders; Florin M Selaru; Mirte M Streppel; Donald J Lucas; Noushin Niknafs; Violeta Beleva Guthrie; Anirban Maitra; Pedram Argani; G Johan A Offerhaus; Juan Carlos Roa; Lewis R Roberts; Gregory J Gores; Irinel Popescu; Sorin T Alexandrescu; Simona Dima; Matteo Fassan; Michele Simbolo; Andrea Mafficini; Paola Capelli; Rita T Lawlor; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Filippo de Braud; Aldo Scarpa; William Jarnagin; David Klimstra; Rachel Karchin; Victor E Velculescu; Ralph H Hruban; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Laura D Wood
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

8.  BAP1 loss defines a new class of renal cell carcinoma.

Authors:  Samuel Peña-Llopis; Silvia Vega-Rubín-de-Celis; Arnold Liao; Nan Leng; Andrea Pavía-Jiménez; Shanshan Wang; Toshinari Yamasaki; Leah Zhrebker; Sharanya Sivanand; Patrick Spence; Lisa Kinch; Tina Hambuch; Suneer Jain; Yair Lotan; Vitaly Margulis; Arthur I Sagalowsky; Pia Banerji Summerour; Wareef Kabbani; S W Wendy Wong; Nick Grishin; Marc Laurent; Xian-Jin Xie; Christian D Haudenschild; Mark T Ross; David R Bentley; Payal Kapur; James Brugarolas
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

9.  The aurora B kinase and the polycomb protein ring1B combine to regulate active promoters in quiescent lymphocytes.

Authors:  Alberto Frangini; Marcela Sjöberg; Monica Roman-Trufero; Gopuraja Dharmalingam; Vanja Haberle; Till Bartke; Boris Lenhard; Marcos Malumbres; Miguel Vidal; Niall Dillon
Journal:  Mol Cell       Date:  2013-09-12       Impact factor: 17.970

10.  BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.

Authors:  Katie A Matatall; Olga A Agapova; Michael D Onken; Lori A Worley; Anne M Bowcock; J William Harbour
Journal:  BMC Cancer       Date:  2013-08-05       Impact factor: 4.430

View more
  30 in total

Review 1.  Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.

Authors:  Efthymia Soura; Philip J Eliades; Kristen Shannon; Alexander J Stratigos; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2016-03       Impact factor: 11.527

2.  Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.

Authors:  Yasaman Arjmand Abbassi; Claudia Le Guin; Norbert Bornfeld; Nikolaos E Bechrakis; Michael Zeschnigk; Dietmar R Lohmann
Journal:  Fam Cancer       Date:  2022-08-03       Impact factor: 2.446

Review 3.  BAP1: Not just a BRCA1-associated protein.

Authors:  Bryan H Louie; Razelle Kurzrock
Journal:  Cancer Treat Rev       Date:  2020-08-20       Impact factor: 12.111

4.  The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.

Authors:  Salima Daou; Ian Hammond-Martel; Nazar Mashtalir; Haithem Barbour; Jessica Gagnon; Nicholas V G Iannantuono; Nadine Sen Nkwe; Alena Motorina; Helen Pak; Helen Yu; Hugo Wurtele; Eric Milot; Frédérick A Mallette; Michele Carbone; El Bachir Affar
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

Review 5.  Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.

Authors:  Louis Masclef; Oumaima Ahmed; Benjamin Estavoyer; Bruno Larrivée; Nathalie Labrecque; Anastasia Nijnik; El Bachir Affar
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 12.067

Review 6.  Roles of the BAP1 Tumor Suppressor in Cell Metabolism.

Authors:  Anna Han; Timothy J Purwin; Andrew E Aplin
Journal:  Cancer Res       Date:  2021-01-14       Impact factor: 13.312

7.  Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.

Authors:  Sushmita Bhattacharya; Pranita Hanpude; Tushar Kanti Maiti
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

Review 8.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

Review 9.  Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.

Authors:  Michele Carbone; J William Harbour; James Brugarolas; Angela Bononi; Ian Pagano; Anwesha Dey; Thomas Krausz; Harvey I Pass; Haining Yang; Giovanni Gaudino
Journal:  Cancer Discov       Date:  2020-07-20       Impact factor: 38.272

Review 10.  DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets.

Authors:  Adan Pinto-Fernandez; Benedikt M Kessler
Journal:  Front Genet       Date:  2016-07-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.